Lemaitre Vascular (LMAT) Reports In-Line Q4 EPS; Issues Mixed Outlook

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.23, in-line with the analyst estimate of $0.23. Revenue for the quarter came in at $30.2 million versus the consensus estimate of $30.44 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2020 EPS of $0.14-$0.17, versus the consensus of $0.21. Lemaitre Vascular sees Q1 2020 revenue of $30.5-31.7 million, versus the consensus of $31.4 million.

Lemaitre Vascular sees FY2020 EPS of $0.90-$0.98, versus the consensus of $0.95. Lemaitre Vascular sees FY2020 revenue of $127.4-130.8 million, versus the consensus of $129.4 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Empire Petroleum posts $11.1M revenue in Q2 2026, narrows net loss
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)